BioCryst Pharmaceuticals Inc (BCRX)
7.485
+0.18
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
7.485
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Gross Profit Margin (Quarterly): 97.24% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 97.24% |
| June 30, 2024 | 98.41% |
| March 31, 2024 | 98.50% |
| December 31, 2023 | 98.25% |
| September 30, 2023 | 98.69% |
| June 30, 2023 | 98.85% |
| March 31, 2023 | 98.64% |
| December 31, 2022 | 96.86% |
| September 30, 2022 | 95.24% |
| June 30, 2022 | 99.62% |
| March 31, 2022 | 99.52% |
| December 31, 2021 | 99.11% |
| September 30, 2021 | 98.50% |
| June 30, 2021 | 99.31% |
| March 31, 2021 | 68.92% |
| December 31, 2020 | 97.98% |
| September 30, 2020 | 74.99% |
| June 30, 2020 | |
| March 31, 2020 | 98.57% |
| December 31, 2019 | 93.53% |
| September 30, 2019 | 98.99% |
| June 30, 2019 | 98.20% |
| March 31, 2019 | 74.76% |
| December 31, 2018 | 97.44% |
| September 30, 2018 | 98.76% |
| Date | Value |
|---|---|
| June 30, 2018 | 98.06% |
| March 31, 2018 | 96.48% |
| December 31, 2017 | 96.68% |
| September 30, 2017 | 85.65% |
| June 30, 2017 | 99.29% |
| March 31, 2017 | 96.88% |
| December 31, 2016 | 72.70% |
| September 30, 2016 | 98.16% |
| June 30, 2016 | 99.44% |
| March 31, 2016 | 98.40% |
| December 31, 2015 | 99.39% |
| September 30, 2015 | 87.70% |
| June 30, 2015 | 98.29% |
| March 31, 2015 | 98.90% |
| December 31, 2014 | 99.19% |
| September 30, 2014 | |
| June 30, 2014 | 99.66% |
| March 31, 2014 | 97.89% |
| December 31, 2013 | 99.84% |
| September 30, 2013 | |
| June 30, 2013 | 99.51% |
| March 31, 2013 | 97.83% |
| December 31, 2012 | 99.56% |
| September 30, 2012 | 98.02% |
| June 30, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
68.92%
Minimum
Mar 2021
99.62%
Maximum
Jun 2022
95.30%
Average
98.50%
Median
Mar 2024
Gross Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 77.14% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 53.37% |
| Electromed Inc | 78.34% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -25.05% |
| Return on Invested Capital | -34.87% |
| Profit Margin (Quarterly) | -11.99% |
| Operating Margin (Quarterly) | 6.57% |
| Return on Net Operating Assets | -133.5% |